RAMMF News and Press, RAMM Pharma

Not for Dissemination in the US or through US Newswire Services TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , is providing an update on its dispute with Sergio Martines an...

TORONTO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the “...

TORONTO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the ȁ...

TORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- On September 5 th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the &...

TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announces that it intends to complete a non-brokered private placement of up to 20,000,000 units (the " Units ") of the Compa...

TORONTO, Dec. 09, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , is pleased to announce the appointment of José Roldan as interim-Chief Financial Officer of the Company, effective immediatel...

TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , is pleased to announce that today it has acquired all of the issued and outstanding shares of HemPoland S.p.a. Z.o.o. (...

TORONTO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. ( CSE: RAMM ) (the “ Company ”). On February 22, 2022, the Company announced that, for reasons set out in its news release of February 22, 2022, the filing of its annual audited financial statements for the y...

TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. ( CSE: RAMM ) (the “ Company ”) announces today that it has made an application to relevant Canadian securities regulators to approve a temporary management cease trade order (" MCTO ") under National Pol...

TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to provide an update on their European operations ...